Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

bioAffinity Technologies (BIAF) Gross Profit: 2022-2025

Historic Gross Profit for bioAffinity Technologies (BIAF) over the last 4 years, with Sep 2025 value amounting to $503,855.

  • bioAffinity Technologies' Gross Profit fell 44.65% to $503,855 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 million, marking a year-over-year decrease of 42.47%. This contributed to the annual value of $3.4 million for FY2024, which is 326.79% up from last year.
  • Per bioAffinity Technologies' latest filing, its Gross Profit stood at $503,855 for Q3 2025, which was up 99.25% from $252,881 recorded in Q2 2025.
  • In the past 5 years, bioAffinity Technologies' Gross Profit registered a high of $989,942 during Q2 2024, and its lowest value of -$1.1 million during Q2 2022.
  • In the last 3 years, bioAffinity Technologies' Gross Profit had a median value of $503,855 in 2025 and averaged $492,058.
  • As far as peak fluctuations go, bioAffinity Technologies' Gross Profit spiked by 99,774.10% in 2024, and later crashed by 74.45% in 2025.
  • Quarterly analysis of 4 years shows bioAffinity Technologies' Gross Profit stood at $2,171 in 2022, then spiked by 25,164.72% to $548,497 in 2023, then increased by 17.67% to $645,427 in 2024, then plummeted by 44.65% to $503,855 in 2025.
  • Its Gross Profit was $503,855 in Q3 2025, compared to $252,881 in Q2 2025 and $485,737 in Q1 2025.